COVID-19 in a Kidney Transplant Patient

Eur Urol. 2020 Jun;77(6):769-770. doi: 10.1016/j.eururo.2020.03.036. Epub 2020 Apr 6.

Authors

Junpeng Wang¹, Xin Li², Guanghui Cao¹, Xiaoqiang Wu¹, Zhiwei Wang¹, Tianzhong Yan³

Affiliations

¹ Department of Urology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.
² Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China; Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou, China.
³ Department of Urology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China. Electronic address: ytz460@hotmail.com.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antiviral Agents / administration & dosage
Betacoronavirus / immunology
Betacoronavirus / pathogenicity*
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy
Coronavirus Infections / immunology
Coronavirus Infections / therapy
Coronavirus Infections / transmission
Coronavirus Infections / virology*
Humans
Immunocompromised Host
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / adverse effects
Kidney Transplantation / adverse effects*
Male
Middle Aged
Opportunistic Infections / immunology
Opportunistic Infections / therapy
Opportunistic Infections / transmission
Opportunistic Infections / virology*
Oxygen Inhalation Therapy
Pandemics
Pneumonia, Viral / immunology
Pneumonia, Viral / therapy
Pneumonia, Viral / transmission
Pneumonia, Viral / virology*
SARS-CoV-2
Transplant Recipients*
Treatment Outcome

Substances

Antiviral Agents
Immunosuppressive Agents